{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-002061","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.196656+00:00","generated_at":"2026-06-07T00:35:26.360962+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"AgeX Therapeutics appoints Steven Mintz to Board of Directors, effective Jan 8, 2024","bullets":["Board of Directors expanded to four members; Steven Mintz appointed as director effective Jan 8, 2024.","Mintz serves on Audit, Compensation, and Nominating committees. He is a financial consultant and director at Portage Biotech.","Receives cash fee of $34,331 and options to purchase 63,756 shares of AgeX common stock for 2024 service.","Additional cash fee of $9,809 for Audit Committee chair role. Fees and options vest quarterly through Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-002061","json":"https://secwatch.observer/filing/0001493152-24-002061.json","markdown":"https://secwatch.observer/filing/0001493152-24-002061.md","text":"https://secwatch.observer/filing/0001493152-24-002061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224002061/0001493152-24-002061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224002061/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:35:26.360962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"96d4f7a1e7","claim":"Steven Mintz was appointed as Director at Serina Therapeutics, Inc..","evidence_excerpt":"On January 8, 2024, the AgeX Board of Directors increased the size of the Board of Directors (the “Board”) to four directors and appointed Steven Mintz as a director to fill the new vacancy on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224002061/0001493152-24-002061-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}